All News

I recently decided to stop feeling like a victim in life after cancer. Instead, I’ll celebrate life every day.

A woman with stage 2 invasive ductal carcinoma — a type of breast cancer that begins in the milk ducts of the breast — shares how her experience as an employee at a breast cancer research facility helped her push against doctors who minimized her ultrasound findings and how her Ki-67 score informed her treatment choices.

Watch Dr. Jared Weiss, from UNC School of Medicine, discuss neoadjuvant versus adjuvant therapy during the CURE Educated Patient Lung Cancer Summit.

Historically, there has been limited evidence to suggest the appropriate treatment sequencing of this melanoma patient population. However, new findings demonstrate starting with Opdivo plus Yervoy followed by Tafinlar in combination with Mekinist may be the best option.

In this poem, I chronicle "Suzy Q's" experience with acute lymphoblastic leukemia.

“Novel approaches to immunotherapy, targeted therapy and combinations with standard chemotherapy are all areas of current research interest,” says an expert at Dana-Farber Cancer Institute Sarcoma Center in Boston. “(Secondary breast cancer) can be very challenging when it recurs, so we need to continue to work toward improving systemic therapies through ongoing international trials and collaboration across the community of patients and physicians. That’s what’s going to help us improve outcomes.”

A professional illustrator and former cancer caregiver uses a detailed step-by-step approach using simple shapes such as circles and rectangles to demonstrate how others can easily draw a lion.

Twenty years of FDA approvals for the treatment of metastatic kidney cancer have allowed patients to live longer.

The Food and Drug Administration granted a priority review to Trodelvy for previously treated locally advanced or metastatic HR-positive, HER2-negative breast cancer.

The designation of HER2-low status is rapidly reshaping how researchers and care providers not only think about, but also treat, breast cancer.

I wish “Pinktober” was more about saving the people who will die from breast cancer and less about pink ribbons and sexualizing the disease.

“I believe the key for many is to turn prostate cancer from a lethal disease to a chronic disease. That’s what we’re trying to do,” says an expert at the University of California, San Francisco.

Ten years after my brain cancer diagnosis, I feel hopeful and content with my life.

The FDA granted a fast track designation to an investigational drug alone and in combination with Keytruda to treat patients with HPV recurrent/metastatic head and neck squamous cell carcinoma.

CURE® surveyed its audience to gather insight into what unexpected lessons cancer has taught them. Here’s what they had to say.

It’s easy to question treatment choices patients with cancer make, but my job as the mother of a patient was to be supportive.

In 2018, 18 trekkers completed an awe-inspiring hike of the Himalayan highlands to the doorstep of the world’s tallest mountain, Mount Everest, to raise awareness and funding for multiple myeloma, a type of blood cancer. Three of the climbers discuss a bond that hasn’t broken.

I went from being an avid runner to running from information about my lung cancer. But now I embrace my diagnosis and am an active participant in my care.

I didn’t let my cancer diagnoses get in the way of living life.

An oncology nurse and cancer survivor inspired another person with lung cancer to “continue the fight to live.”

Dr. Estelamari Rodriguez serves patients with lung cancer in more than just a clinical capacity, her Lung Cancer Hero® nominator wrote.

I turned my cancer-related depression and frustration with the health care system into something positive for others with the disease.

Walking has played a key role in my cancer experience, as it helps my mental and physical health.

From the death of standup comedian and "Love Goddess" Judy Tenuta to professional sports hall-of-famers discussing their cancer, here’s what’s happening in the cancer space this week.

Talzenna Plus Xtandi lengthened time to progression in men with metastatic castration-resistant prostate cancer.

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Dr. Daniel P. Petrylak about survivorship in prostate cancer.

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Dr. Daniel P. Petrylak about the long-term effects associated with a prostate cancer diagnosis.

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Dr. Daniel P. Petrylak about PSMA, what it is and how it is advancing the prostate cancer landscape.